The PI3K/Akt/NF-kβ signaling acts an essential role in cancer therapy through regulation of cell proliferation, apoptosis, and angiogenesis and alterations in this pathway are significant contributors to tumor drug resistance [19]. This evidence concerns the gene AKT1 and neoplasm.